Strong

Our patients don’t just live with diabetes, they thrive with diabetes.

Leading

We’re constantly pushing forward toward the next great discovery.

George L. King, MD, Chief Scientific Officer at Joslin Diabetes Center Named to Newly Endowed Professorship at Harvard Medical School

Boston – (March 11, 2022) – Joslin Diabetes Center is pleased to announce that Chief Scientific Officer George L. King, MD, section head of vascular cell biology, has been named the inaugural incumbent of the Thomas J. Beatson, Jr. Professorship in the Field of Diabetes at Harvard Medical School (HMS). King also holds a secondary appointment as Professor of Ophthalmology at HMS. This newly...
Harvard Medical School

Joslin Diabetes Center Receives $8.5 Million for NIH-Sponsored Diabetes Research Center (DRC) Program

Boston, MA – (April 21, 2022) – Joslin Diabetes Center, the preeminent institution for diabetes research and care, affiliated with Harvard Medical School and a part of Beth Israel Lahey Health, has...
Read more on Joslin Diabetes Center Receives $8.5 Million for NIH-Sponsored Diabetes Research Center (DRC) Program

Dr. Rosas joins study focused on improving kidney transplant outcomes

At Joslin Diabetes Center, we are proud to be the global leader in diabetes research. This important research includes identifying ways to improve diabetes-related issues such as kidney disease...
Read more on Dr. Rosas joins study focused on improving kidney transplant outcomes
Female chemist at work in laboratory.

Women in Diabetes Research and Care

Women in Diabetes Research and Care

In recognition of International Women’s Day on March 8, 2022, meet some of the relentless, strong and heroic women leading the pioneering care and research at Joslin Diabetes Center.
Read more on Women in Diabetes Research and Care

Women in Diabetes Research and Care

In recognition of International Women’s Day on March 8, 2022, meet some of the relentless, strong and heroic women leading the pioneering care and research at Joslin Diabetes Center.
Female chemist at work in laboratory.

Long-running Joslin study leads to potential therapeutic target for people with type 1 diabetes

Researchers demonstrate enzyme can protect kidneys against toxic effects of hyperglycemia in mouse models BOSTON – Nearly two million Americans have type 1 diabetes, a condition in which the body does...
Read more on Long-running Joslin study leads to potential therapeutic target for people with type 1 diabetes
Drs wearing masks

Joslin and COVID-19

Joslin and COVID-19

Joslin is committed to providing a safe environment for our staff and patients and therefore all COVID-19 prevention practices remain in place at Joslin. Please note: If you are coming to Joslin for...
Read more on Joslin and COVID-19

Diabetes Centers Offer Comprehensive Care

Sylvia Rosas at the Harvard-affiliated Joslin Diabetes Center in Boston, a weekly Latino Kidney Clinic helps screen and treat the especially high rates of diabetes-related kidney disease in Hispanic...
Read more on Diabetes Centers Offer Comprehensive Care